Olsalazine

Overview

Olsalazine is an orally active prodrug of 5-ASA ( HY-15027 ). Olsalazine can inhibit cells proliferation and induce apoptosis . Olsalazine can reduce DAI and MPO activity and inhibit inflammatory cytokines levels. Olsalazine can be used for the researches of cancer , inflammation and metabolic disease , such as colorectal cancer , inflammatory bowel disease (IBD) and hyperuricemic.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-B0174A
• CAS No.: 15722-48-2
• Molecular Formula: C14H10N2O6
• Molecular Weight: 302.24
• Purity: 99.83%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2 mg/mL (6.62 mM); Clear solution
• Availability: In-stock

Source

Original product source